Review Boards at each ARIC site approved the study protocol. All participants provided written informed consent, and all procedures were in accordance with institutional guidelines about the protection of human subjects.
Clinical Assessment
Each participant underwent a comprehensive evaluation of cardiovascular risk factors, including standardized BP measurement at baseline, and was followed through December 31, 2008 for the incidence of cardiovascular events and death, ascertained according to criteria defined previously (see the online-only Data Supplement).
Statistical Analyses
For individuals taking antihypertensive medication at the time of BP measurement, we added 10 mm Hg to SBP and 5 mm Hg to DBP. 10 PP was calculated as SBP minus DBP, and MAP was calculated as DBP+1/3 PP. 2, 11 We assessed incidence rates for each cardiovascular outcome (new-onset CHD, HF, and stroke) and death for individuals in the upper compared with lower quartile of each baseline BP measure (SBP, DBP, PP, and MAP). Multivariable analyses adjusted for baseline age, sex, body mass index, total/high-density lipoprotein cholesterol ratio, diabetes mellitus, smoking status, and resting heart rate. Electrocardiographic evidence of left ventricular hypertrophy was additionally included as a binary covariate for incident HF. Analyses of HF were also performed excluding individuals who developed CHD previous to the onset of incident HF.
In multivariable-adjusted Cox regression analyses, we examined the association of BP measures with each outcome and included quadratic terms for each BP measure. 2, 7 We compared the model fit between BP measures for each cardiovascular outcome, using separate models that included only a single BP measure (with a linear and a quadratic term for that BP measure) in addition to the covariates listed above. For each model, we determined area under the receiver-operating characteristic curve (AUC) and compared these values between models to assess model fit for each BP measure. Although AUC is considered particularly appropriate for assessing model fit for binary outcomes, 12 we also used the −2 log-likelihood, Akaike information criterion, and Bayes' information criterion estimates to assess model fit.
In secondary analyses, we repeated the main analyses in individuals not taking antihypertensive therapy. We also performed analyses stratified by age (<60 and ≥60 years), sex, and race (black versus nonblack) to assess differences between subgroups. Additionally, we repeated the main analyses using component variables derived from principal components analyses performed on SBP and DBP in the total sample, and in the sample of individuals not taking antihypertensive medications (see the online-only Data Supplement).
All analyses were performed using STATA version 11.2 (College Station, TX), and a 2-tailed P value <0.05 was considered statistically significant. Graphical displays were created using the image, points, and contour functions in R (R Development Core Team, Vienna, Austria).
Results
In the total study sample (Table 1) , 56% were women, 27% were self-identified as black, and the baseline age of participants was 53.9±5.7 years. Baseline SBP was strongly correlated with DBP (r=0.73), MAP (r=0.92), and PP (r=0.82); DBP was also strongly correlated with MAP (r=0.94) but not PP (r=0.20); MAP and PP were moderately correlated with each other (r=0.52).
During 22 years of follow-up (mean, 18±5 years), there were 2095 CHD events, 1669 HF events, 771 stroke events, and 3016 deaths. Unadjusted incidence rates of CHD are shown in Table S1 in the online-only Data Supplement. Incidence rates of HF and all-cause mortality were higher among individuals in the upper quartile of PP than among those in the upper quartiles of the other BP measures, whereas the incidence of stroke was higher among individuals in the upper quartile of SBP than among those in the upper quartiles of the other BP measures.
Although SBP and PP values were strongly correlated in our sample, their associations with cardiovascular risk were not identical (Table S1 ). As shown in the Figure, CHD risk seemed to increase incrementally with both SBP and PP. However, risk for HF and death increased substantially more with even small elevations in PP compared with SBP values; a similar pattern was noted for all-cause mortality. By contrast, risk for stroke increased more steadily with elevations in SBP than in PP.
Multivariable-adjusted incidence rates of CHD were the highest among individuals in the upper quartile of SBP (Table 2) ; findings were otherwise similar to those from unadjusted incidence analyses (Table S1 ). In Cox proportional hazards models, multivariable-adjusted contributions of each BP measure to the risk of each outcome were estimated in the total study sample ( Table 3 ). The BP measure demonstrating the best model fit for predicting risk of CHD was SBP, based on its association with the highest AUC value as well as the lowest −2 log-likelihood, Akaike information criterion, and Bayes' information criterion values; similar results were seen for the association of SBP with incident stroke. However, the BP measure offering the best model fit for predicting HF risk was PP. For risk of all-cause mortality, PP was associated with slightly higher AUC than SBP, whereas −2 log-likelihood, Akaike information criterion, and Bayes' information criterion values were similar for the 2 BP measures.
In secondary analyses, results of the main analyses performed in the subset of individuals not taking any antihypertensive medications (n=10 525) were similar to those performed in the total sample (Table S2 ). However, PP was more clearly a stronger contributor to all-cause mortality than SBP in this subsample, based on associations with the lowest values of −2 log-likelihood, Akaike information criterion, and Bayes' information criterion values as well as the highest value of AUC. In analyses stratified by age group, results were again similar to those in the total sample (Table S3) . With respect to risk for death among individuals <60 years, the AUC value was slightly higher for PP than SBP, although other metrics of model fit were slightly lower for SBP than for PP; overall, both SBP and PP seemed to contribute relatively equality to mortality risk in this age group. There were otherwise no notable age-based differences in results for other end points, when compared with those in the total sample.
In sex-specific analyses, results were similar to those from sex-pooled analyses for all end points except for stroke (Table  S4 ). In men, MAP was the most prominent contributor to increased risk for stroke; by contrast, increased SBP remained the strongest predictor of stroke in women. Findings for HF Figure. Twenty-year risk estimates for each of the main outcomes are plotted for participants (denoted by black dots) across varying levels of systolic blood pressure (SBP) and pulse pressure (PP). Actual risk estimates are denoted by labeled contour lines, and the gradient of relatively lower vs higher risk for a given outcome is denoted by white (lowest), yellow to orange (moderate), and red (highest) background colors. As shown in A, risk for coronary heart disease increased steadily with elevations in both SBP and PP. B, Heart failure risk increased primarily in association with rising PP, as denoted by more vertical contour lines representing risk estimates. were similar by sex, although both SBP and PP seemed to contribute relatively equally to HF risk among women. Both SBP and PP seemed to contribute relatively equally to risk of mortality among men.
In analyses stratified by race, patterns of BP associations with incident stroke were similar in blacks and nonblacks but differed by race for other the outcomes (Table S5) . SBP accounted for the greatest risk for CHD in nonblacks, whereas MAP accounted for the greatest risk for CHD in blacks. With respect to risk for HF, PP was the strongest predictor in nonblacks, consistent with findings in the total sample, whereas SBP contributed the greatest risk in blacks. With respect to risk for stroke, SBP was the strongest BP risk predictor in blacks and nonblacks, consistent with findings in the total sample. For all-cause mortality, SBP was the strongest risk contributor in blacks, whereas PP contributed the greatest risk in nonblacks.
Principal components analyses generated the following 
Discussion
In data collected from a large multicenter and biracial community-based cohort, followed during a period of 2 decades, we observed that distinct components of BP elevation contribute variably to different cardiovascular outcomes. Overall, SBP was the most prominent BP contributor to incident stroke, whereas PP was the predominant BP contributor to risk for HF. Previous studies have examined the relative importance of BP component measures with cardiovascular outcomes but with inconsistent results, likely related to methodological challenges. These challenges include the collinearity between BP measures, potential nonlinear relationships between BP measures and outcomes, and likelihood of effect modification by factors such as age, sex, and race. Few studies have used measures of model fit to formally assess the contribution of the BP components to different cardiovascular outcomes. 7, 13, 14 Fewer still have used methods accounting for nonlinearity of associations between BP and outcomes. 2, 7 Furthermore, the majority of previous studies have been limited to predominantly older or younger samples, or samples selected based on demographic characteristics or hypertension status. Importantly, there have been no reported analyses of BP components and different cardiovascular outcomes in blacks, among whom the prevalence and associated risks of hypertension are especially high. 1, 15 Thus, the present study builds on previous work by comprehensively examining the relative contributions of all BP components to different cardiovascular outcomes in a large community-based cohort comprising middle-aged to elderly men and women, representing predominantly blacks and whites.
BP Predictors of CHD
The extent to which SBP versus PP is the most important BP predictor of CHD has been controversial. [16] [17] [18] [19] Most studies have indicated the dominance of SBP for predicting CHD, All analyses are adjusted for age, sex, race, site, body mass index, total/high-density lipoprotein cholesterol ratio, diabetes mellitus, smoking status, and heart rate. Analyses of heart failure excluded individuals who developed coronary heart disease before their first heart failure event and additionally adjusted for electrocardiographic left ventricular hypertrophy. CI indicates confidence interval; DBP, diastolic blood pressure; MAP, mean arterial pressure;
PP, pulse pressure; and SBP, systolic blood pressure. *Incidence rates are per 1000 person-years. †Values signify the highest incidence rates per outcome. as well as cardiovascular disease, overall. In the somewhat younger Chicago Heart Association cohort (mean age, 39±13 years), both SBP and PP were associated with incident CHD mortality, 20 but SBP had the greater predictive value. 14 In an older cohort from the Cardiovascular Health Study (mean age, 73±6 years), SBP was also found to be most strongly associated with myocardial infarction. 16 In our sample (mean age, 54±6 years), SBP was also the overall strongest predictor of incident CHD. This finding is supported by studies of ambulatory BP, suggesting that 24-hour SBP compared with other measures is more consistently associated with cardiovascular events (the majority of which were coronary events) across age group and sexes. 21 However, in our biracial study sample, we further observed that MAP was the more prominent contributor to CHD risk in blacks. Importantly, previous studies have also noted decreased small artery elasticity in blacks compared with other racial/ethnic groups, 22 potentially related to reduced endothelial function that can manifest as early as in adolescence. 23 Such race-based differences in arterial hemodynamics could contribute to the observed incidence of CHD at lower ages in blacks compared with nonblacks.
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BP Predictors of Stroke
There has been much interest in which BP measure most strongly predicts stroke, and previous studies have been conflicting. Studies in hypertensives have suggested that the most important BP predictor of stroke is MAP, [25] [26] [27] which is closely related to mean cerebral perfusion and small vessel disease. Other studies, including those using model fit criteria to assess relative importance of BP components, have indicated that SBP and particularly PP confer greater risk for stroke, 18, 28 supporting the hypothesis that increased pulsatile load plays a more prominent role in the development of cerebrovascular disease. Data from the Chicago Heart Association and Cardiovascular Health Study cohorts suggest that, in fact, SBP provides the greatest predictive ability.
14, 16 Our overall results are consistent with these findings, where SBP was the strongest predictor of stroke regardless of age group. Our results are also consistent with studies suggesting that 24-hour SBP is the primary contributor to stroke risk when compared with other 24-hour BP measures. 29 However, in sex-stratified analyses, we observed that MAP was more important in men. These results fit with known patterns of age-related BP elevation 30 (characterized by increased DBP and MAP earlier in life followed by increased SBP and PP later in life) and the consistent finding that men tend to present with stroke at a younger age than women. 31 The age-based differences between men and women in the initial presentation of stroke are not completely explained by survivor bias in women, and are likely related to biological mechanisms that have yet to be identified. 32 Possible contributors include the influence of estrogen and testosterone balance on the endothelium 33 as well as neurohormonal axis. 34 The pathophysiology underlying the sex-dependent relationship between MAP and stroke warrants further study.
BP Predictors of HF
With respect to BP predictors of HF, most of the previous literature has focused on PP as a surrogate measure of arterial stiffness. Indeed, coupling of abnormalities in cardiac and arterial function has been proposed as a mechanistic precursor to HF with either preserved or reduced ejection fraction. 35, 36 Accordingly, PP was demonstrated as the strongest BP predictor of incident HF in studies of older adults, including the Cardiovascular Healthy Study 17 and a large cohort of postmenopausal women with baseline CHD. 18 In contrast, SBP was more predictive than PP of incident HF in the overall younger Chicago Heart Association cohort.
14 Extending from previous work, we observed that PP was consistently the strongest predictor of HF regardless of age and sex. Notably, PP has been related to incident HF even in studies that did not observe an association between more direct measures of arterial stiffness with HF; this phenomenon is thought possibly because of survivor bias and hemodynamic changes impacting the relationship between cardiac and arterial function during the later stages of subclinical disease progression. 37 In the present study, both SBP and PP conferred risk for HF in blacks, whereas PP remained the strongest risk contributor in nonblacks. This finding may be related to the younger age of HF presentation in blacks compared with nonblacks, 38 and factors that have yet to be determined. Taken together with previous reports, our overall findings suggest that conduit artery stiffening, manifesting as elevated PP, is likely part of the common pathway leading to the development of HF in a majority of individuals at risk. All models included a quadratic term (in addition to the linear term) for each BP variable and adjusted for age, sex, race, site, body mass index, total/HDL cholesterol ratio, diabetes mellitus, smoking status, and heart rate. Analyses of HF excluded individuals who developed CHD previous to their first HF event and additionally adjusted for electrocardiographic left ventricular hypertrophy. AIC indicates Akaike information criterion; AUC, area under the receiver-operating curve; BIC, Bayes' information criterion; BP, blood pressure; CHD, coronary heart disease; DBP, diastolic blood pressure; HF, heart failure; MAP, mean arterial pressure; PP, pulse pressure; and SBP, systolic blood pressure. 
BP Predictors of All-Cause Mortality
The extent to which SBP or PP confers greater risk for overall mortality has been unclear. 16, 39, 40 We used several measures of model fit in a middle-aged to elderly sample and observed that PP seemed to be the strongest BP predictor of all-cause mortality overall. This finding is consistent with previous studies that have included more detailed measures of BP and observed that measures of central or 24-hour ambulatory PP are more predictive of all-cause mortality than central or ambulatory SBP. 41, 42 In subgroup analyses, SBP was a relatively equal contributor to mortality risk in younger individuals and among men; SBP seemed to be a stronger predictor of death among blacks. Because increased PP reflects arterial stiffening, a well-recognized hallmark of vascular aging, hypertension is more likely to manifest as elevated SBP than elevated PP in younger compared with older patients 30 ; this phenomenon could at least partly account for the more prominent relationship between SBP and mortality in men and in blacks, in whom death from any cause is more likely to occur at a younger age when compared with their counterparts.
Several limitations of the present study merit consideration. Measurements of BP were performed at only a single point in time rather than using 24-hour monitoring. In addition, we did not analyze central measures of BP, which likely reflect central arterial hemodynamics more accurately. Therefore, further studies of BP variability and using more direct measures of BP are needed. Nonetheless, our method of recording the average of 2 consecutive brachial BP measurements performed at rest is considered practical and reliable for assessment of BP in a large epidemiological cohort. 43 We observed that differences in AUC between separate models were relatively small; thus, these differences were not formally tested for statistical significance. The relatively small differences in AUC also underscore the importance of interpreting our study results in the context of investigating the potential pathobiology of different aspects of arterial hypertension, rather than attempts to draw conclusions about prediction. Although our cohort included individuals across a spectrum of age, our study sample was predominantly middle-aged to older and predominantly either white or black with respect to racial/ethnic group. Thus, the generalizability of our findings to other age and racial/ethnic groups is not known. Nonetheless, our sample is relatively representative of the majority of patients known to have either controlled or uncontrolled hypertension.
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Perspectives
We examined the relative contributions of all BP components to different cardiovascular outcomes in a large communitybased cohort comprising middle-aged to elderly men and women, representing both blacks and whites. Overall, we observed that elevated SBP was the strongest BP predictor of stroke, whereas increased PP was the most important predictor of incident HF. Our data provide further insights about the distinct hemodynamic pathways by which different forms of BP elevation may contribute to the development of different cardiovascular disease end points. Further investigations may help to clarify the mechanisms underlying our observations. With respect to potential clinical implications, our findings underscore the importance of assessment and management of multiple BP components.
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What Is New?
• The extent to which elevation in distinct blood pressure components is associated to varying degrees with different cardiovascular outcomes has not been studied comprehensively.
What Is Relevant?
• Understanding the relative contribution of distinct blood pressure components to risk for specific outcomes could have implications for tailoring interventions for lowering cardiovascular risk.
METHODS
Clinical Assessment
At the baseline examination, each study participant underwent a history and physical examination focused on the assessment of cardiovascular risk factors.
1,2 Blood pressure measurement was performed according to a standardized protocol and by a trained and certified technician using a random-zero sphygmomanometer. During the examination, a total of 3 brachial BP measurements were performed with the participant in the sitting position; the average of the second and third measurement was recorded as the baseline BP measurement. Additional details regarding the standardized protocol are included in the manual for ARIC BP measurement that can be accessed at http://www.cscc.unc.edu/aric/pubuse/manual/Sitting_Blood_Pressure_and_Postural_Changes_in_Blood_ Pressure_and_Heart_Rate.1_11.pdf.
Ascertainment of Outcomes
All participants were followed longitudinally through December 31, 2008 for the incidence of new cardiovascular events, ascertained according to previously defined criteria, and death. 1 Incident cardiovascular events included: CHD, HF, and stroke. From a review of outside hospital records and ARIC clinic examination data, a CHD event was defined as a validated definite or probable hospitalized myocardial infarction (based on documented chest pain symptoms, electrocardiographic changes, and cardiac biomarker levels), a definite CHD death (based on chest pain symptoms, cause of death documented on the death certificate, and associated hospital and ARIC clinic information), electrocardiographic evidence of an unrecognized prior MI (a major Q-wave, or a minor Q-wave with associated ST-T changes), or documented coronary revascularization. 2, 3 Upon review of data from hospital discharge records and death certificates, incident HF was defined as hospitalization for HF (based on a combination of documented new or worsening HF signs and symptoms diagnostic tests indicating cardiac dysfunction, natriuretic peptide levels, and response to diuretic therapy) or death with presence of HF listed on the death certificate. 4, 5 Using data collected from hospital records and death certificates, incident stroke was defined as a validated definite or probable hospitalization for ischemic or hemorrhagic stroke (based on documented type of neurologic signs and symptoms, duration and severity of physical findings, and results of neuroimaging or other diagnostic procedures) or death with presence of stroke (stroke listed on the death certificate, and autopsy evidence when available). 6 
Statistical Analyses
We also performed principal components analyses on SBP and DBP, as previously described. 7 Two principal component variables (i.e. Component 1 and Component 2) were newly generated as the weighted sum and difference of the SBP and DBP variables. We performed Spearman correlation analyses to assess the relationship between the 2 principal component variables and SBP, DBP, PP, and MAP. Correlation analyses also confirmed that the principal component variables were not correlated with each other. In multivariable Cox regression analyses, we assessed the relative contribution of Component 1 and Component 2 with each outcome. As in the main analyses, we determined the AUC and additional measures of model fit (-2 loglikelihood, AIC, and BIC) for each model.
RESULTS
Principal components analyses performed on SBP and DBP generated the following 2 new variables, as shown in Table S5 Table S6) . Results were similar in the subset of individuals not taking anti-hypertensive medications (data not shown). Notably, Components 1 and 2 were not correlated with each other. In multivariable-adjusted analyses, Component 1 compared to Component 2 was the greater contributor to risk for all outcomes, based on measures of model fit (Table S7 ). These findings are consistent with the main study results, indicating that SBP and PP are the primary BP contributors to risk. 
